{
    "nctId": "NCT01814150",
    "briefTitle": "The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel",
    "officialTitle": "The Association Between Alpha 1 Acid Glycoprotein Level and Outcome of Patients With Metastatic Cancer Treated With Docetaxel Based Chemotherapy",
    "overallStatus": "UNKNOWN",
    "conditions": "Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Metastatic Prostate Cancer, Metastatic Bladder Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "The association between the baseline plasma level of alpha 1 acid glycoprotein and progression free survival of docetaxel based therapy in patients with metastatic cancer",
    "eligibilityCriteria": "Inclusion Criteria\n\n* patients with metastatic cancer from lung, breast, gastric, prostate, and bladder origin\n* patients must be treated with docetaxel based chemotherapy\n* patients must sign an informed consent form\n\nExclusion Criteria\n\n* patients with metastatic cancer other than lung, breast, gastric, prostate, and bladder origin\n* patients treated with chemotherapy other than docetaxel\n* patients that did not sign an informed consent form",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}